AZTA
Price
$36.01
Change
-$0.75 (-2.04%)
Updated
Oct 22 closing price
Capitalization
1.58B
29 days until earnings call
Intraday BUY SELL Signals
RXST
Price
$5.08
Change
+$0.18 (+3.67%)
Updated
Oct 22 closing price
Capitalization
211.29M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs RXST

AZTA vs RXST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AZTA vs. RXST commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and RXST is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AZTA with price predictions
Oct 22, 2026

Aroon Indicator for AZTA shows an upward move is likely

AZTA's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 177 similar instances where the Aroon Indicator showed a similar pattern. In 150 of the 177 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 62 cases where AZTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on AZTA as a result. In 66 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

AZTA moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZTA advanced for three days, in 215 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The 10-day RSI Indicator for AZTA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 24 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Moving Average Convergence Divergence Histogram (MACD) for AZTA turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 38 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

AZTA broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.045) is normal, around the industry mean (4.961). P/E Ratio (-13.387) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (4.143). Dividend Yield (0.011) settles around the average of (0.005) among similar stocks. P/S Ratio (2.485) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. AZTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for RXST with price predictions
Oct 22, 2026

RXST's RSI Indicator ascends from oversold territory

The RSI Oscillator for RXST moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In 38 of the 44 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on RXST as a result. In 68 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for RXST just turned positive on October 07, 2026. Looking at past instances where RXST's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.

Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in 234 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for RXST crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

RXST broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RXST entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.802) is normal, around the industry mean (2.874). P/E Ratio (-4.456) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.749) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. RXST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
AZTA: Fundamental Ratings
AZTA
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTARXST
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AZTA: $36.01 vs. RXST: $5.08)
Brand notoriety: AZTA and RXST are both not notable
AZTA represents the Pharmaceuticals: Other, while RXST is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 67% vs. RXST: 50%
Market capitalization -- AZTA: $1.58B vs. RXST: $211.29M
AZTA [@Pharmaceuticals: Other] is valued at $1.58B. RXST’s [@Medical/Nursing Services] market capitalization is $211.29M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 1 FA rating(s) are green while RXST’s FA Score has 2 green FA rating(s).

  • AZTA’s FA Score: 1 green, 4 red.
  • RXST’s FA Score: 2 green, 3 red.
According to our system of comparison, both AZTA and RXST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while RXST’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 4 bearish.
  • RXST’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than RXST.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -1.40% price change this week, while RXST (@Medical/Nursing Services) price change was +8.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 20, 2026.

RXST is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
AZTA
Daily Signal:
Gain/Loss:
RXST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RXST and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GMED. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
+3.67%
GMED - RXST
37%
Loosely correlated
+3.79%
DCTH - RXST
32%
Poorly correlated
+0.34%
STE - RXST
31%
Poorly correlated
+4.85%
AZTA - RXST
28%
Poorly correlated
-2.04%
LUNG - RXST
28%
Poorly correlated
+2.73%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLDR57.544.03
+7.53%
Builders FirstSource
ELV445.2811.15
+2.57%
Elevance Health
VTSI2.700.04
+1.50%
VirTra
UNIT5.19-0.16
-2.99%
Uniti Group Inc
OPTX6.66-0.44
-6.20%
Syntec Optics Holdings